Canagliflozin
Common brands: Invokana, Metformin Hydrochloride, Metformin, Lantus, Zestril
Top reporter: Janssen Pharmaceuticals, Inc.
Insulin Analog [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]GLP-1 Receptor Agonist [EPC]Sulfonylurea [EPC]HMG-CoA Reductase Inhibitor [EPC]
29,639
Total Reports
3,366
Serious Reports
682
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (2.30%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Canagliflozin.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | DIABETIC KETOACIDOSIS | 3,423 | |
| 2 | TOE AMPUTATION | 2,195 | |
| 3 | OSTEOMYELITIS | 2,165 | |
| 4 | ACUTE KIDNEY INJURY | 1,994 | |
| 5 | FUNGAL INFECTION | 1,447 | |
| 6 | WEIGHT DECREASED | 1,341 | |
| 7 | BLOOD GLUCOSE INCREASED | 1,232 | |
| 8 | GANGRENE | 1,084 | |
| 9 | CELLULITIS | 1,035 | |
| 10 | URINARY TRACT INFECTION | 1,018 | |
| 11 | NAUSEA | 1,009 | |
| 12 | OFF LABEL USE | 1,008 | |
| 13 | DRUG INEFFECTIVE | 1,006 | |
| 14 | DIZZINESS | 841 | |
| 15 | DIABETIC FOOT INFECTION | 834 | |
| 16 | LEG AMPUTATION | 792 | |
| 17 | DIABETIC FOOT | 788 | |
| 18 | DIARRHOEA | 774 | |
| 19 | DEHYDRATION | 727 | |
| 20 | RENAL FAILURE | 711 | |
| 21 | KETOACIDOSIS | 642 | |
| 22 | VOMITING | 627 | |
| 23 | FATIGUE | 604 | |
| 24 | FOOT AMPUTATION | 582 | |
| 25 | SEPSIS | 573 | |
| 26 | SKIN ULCER | 570 | |
| 27 | RASH | 522 | |
| 28 | DRUG DOSE OMISSION | 514 | |
| 29 | GLYCOSYLATED HAEMOGLOBIN INCREASED | 514 | |
| 30 | MALAISE | 498 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.